{"product_id":"cetrotide-p1019","title":"Cetrotide","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eCetrotide (NS 75A Acetate, SB 075 Acetate, SB 75 Acetate) is a man-made hormone that blocks the effects of Gonadotropin Releasing Hormone (GnRH) with an IC50 of 1.21 nM. The mapped target for this entry is Gonadotropin-releasing hormone receptor (GNRHR). This target context is most often investigated as part of ligand-responsive signaling, where receptor occupancy can reshape downstream second-messenger output, trafficking, secretion, excitability, or transcriptional programs. In endocrine signaling studies, investigators commonly track ligand-responsive signaling, secretion, and endocrine feedback. This framing is especially useful when investigators want to connect a controlled ligand stimulus with rapidly changing cellular phenotypes.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eAs an antagonist-format peptide, it is well suited to experiments that test pathway dependence, receptor blockade, and the extent to which a phenotype requires ongoing target signaling. In practice, dose-response design, timing, and matched control conditions are important for separating direct target engagement from delayed compensatory responses.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003epair peptide treatment with pathway-proximal signaling or trafficking readouts whenever possible\u003c\/li\u003e\n\u003cli\u003ecompare responses across cell states or model systems with different receptor abundance\u003c\/li\u003e\n\u003cli\u003edistinguish primary target engagement from downstream adaptation during longer incubations\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eExperimental interpretation should therefore connect early pathway changes with later phenotypic outputs, rather than relying on a single endpoint in isolation.\u003c\/p\u003e\u003ch2\u003eFormat Considerations\u003c\/h2\u003e\u003cp\u003eThe standard product format is most useful for reproducible baseline experiments, matched comparative studies, and workflows that need a consistent reagent across assay repeats. In comparative workflows, consistency of preparation, exposure window, and matched controls is often as important as the nominal treatment itself. This is particularly helpful for comparative experiments, benchmark studies, and orthogonal validation in which small differences in formulation or handling can complicate interpretation. For peptide-centered workflows, conclusions are usually strongest when biological readouts are paired with consistent preparation and appropriately matched reference conditions. Researchers often obtain the clearest results when this product is compared with matched controls, orthogonal pathway measurements, and replicate conditions that keep workflow variables constant.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"5 mg","offer_id":57636816879961,"sku":"P1019-5MG","price":144.0,"currency_code":"EUR","in_stock":true},{"title":"25 mg","offer_id":57636816912729,"sku":"P1019-25MG","price":350.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/Cetrorelix-Acetate-Cetrotide-chemical-structure-P1019.gif?v=1774212270","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/cetrotide-p1019","provider":"Absource Diagnostics","version":"1.0","type":"link"}